Aleksey Prok, MD
Interventional Pain Medicine · Lima, OHNPI 1912942400
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,417 of the $3,191 with a category attached, or 75.7%. Medtronic accounts for 61.4% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $1,712 and has fallen 88.4% since, to $198 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in OH, where the typical reported total is $5,193.
Across 108 payments — averaging $29.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$284
- Collegium Pharmaceutical, Inc.$213
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$148
- SPR Therapeutics, Inc$140
- Nevro Corp.$68
- plus $378 from 15 others
What the payments were for
- Travel & lodging$77524%
- Food & beverage$2,41776%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 40 | $1,960 |
| Boston Scientific | 10 | $284 |
| Collegium Pharmaceutical, Inc. | 20 | $213 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $148 |
| SPR Therapeutics, Inc | 5 | $140 |
| Nevro Corp. | 4 | $68 |
| Tersera Therapeutics LLC | 4 | $61 |
| Stryker | 1 | $46 |
| Si-bone, Inc. | 2 | $35 |
| Biodelivery Sciences International, Inc. | 2 | $31 |
| Pfizer | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| Convatec Inc. | 1 | $23 |
| Flowonix Medical Incorporated | 1 | $22 |
| Zyla Life Sciences, Inc. | 1 | $21 |
| Vertex | 1 | $18 |
| Valinor Pharma, LLC | 1 | $17 |
| Amgen | 1 | $16 |
| GRT US Holding, Inc. | 1 | $14 |
| Abbott | 1 | $13 |
| Vertiflex, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,191 in reported general payments places this provider in the 35th percentile of 67 interventional pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 238 | $6,697 |
| Xtampza ErOxycodone Myristate | 13 | $6,651 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 261 | $5,873 |
| Pregabalin | 49 | $5,604 |
| Gabapentin | 104 | $2,121 |
| Oxycodone Hcl | 85 | $1,455 |
| Tramadol Hcl | 141 | $1,276 |
| Fentanyl | 20 | $1,230 |
| Baclofen | 42 | $881 |
| Tizanidine Hcl | 45 | $737 |
| Duloxetine Hcl | 19 | $476 |
| Methadone Hcl | 26 | $368 |
| Morphine Sulfate ErMorphine Sulfate | 11 | $268 |
| Modafinil | 12 | $232 |
| Cyclobenzaprine Hcl | 26 | $152 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $213 | $6,65113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 67 interventional pain medicine providers in Ohio.
Other interventional pain medicine in Lima
- Anuj ShahLima$18K
- Gladstone McDowellColumbus$660K
- Humam AkbikFairfield$116K
- Sara NashiCincinnati$116K
- Jaudat MahmoodKent$97K
- Omar AliSpringfield$67K
- Dustin ReynoldsWesterville$61K
- James OttingToledo$47K
- Mark MalinowskiChillicothe$39K
- David WalegaColumbus$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.